Novant CEO Vows To Improve Hospitals Facing FTC Scrutiny
By Hayley Fowler
Novant Health kicked off its defense Tuesday in the Federal Trade Commission's $320 million merger challenge with testimony from its longtime CEO, who vocalized the health system's promise to reinvest in the two struggling hospitals at the center of the case.